When disaster strikes, how do we rebuild...and do we do it differently? The answer might start with something simpler than we think: listening to the people already living with risk.

In this episode, we chat with Ben Raschnock, Assistant Professor of Industrial and Systems Engineering at North Carolina State University, whose work sits at the intersection of civil engineering, operations research, and real-world decision-making.

Ben studies how disasters don't just destroy things. They cut people off from what they need most. Floodwaters block roads. Power outages shutter grocery stores. A preferred doctor becomes unreachable. His research reframes community resilience through one powerful lens: access to essential services.

We also dive into the bigger picture of aging infrastructure, climate surprises that break models, and why the most valuable data in disaster research might already exist in the community conversations.

Two veteran risk analysts reflect on how scientists, academics, and federal employees (both former and current) are planning for the day agencies can be rebuilt. Adam Finkel, professor at the University of Michigan's School of Public Health and former head of regulation at OSHA, and Vicki Bier, retired faculty from the University of Wisconsin-Madison and former member of the Nuclear Regulatory Commission's Advisory Committee on Reactor Safeguards, make the case that the worst thing reformers could do is simply restore the status quo. After decades of regulatory running on autopilot, a once-in-a-generation disruption may be the opening we've been waiting for.

Biotechnology is advancing faster than ever before, and the stakes have never been higher. In this episode, Dr. Christopher Cummings, lead for the Center for Health Engineering with the U.S. Army Corps of Engineers, breaks down why the convergence of biotech and artificial intelligence is creating both unprecedented opportunities and existential risks.

From gene-edited foods that could revolutionize agriculture to AI-designed viruses that could destabilize nations, Dr. Cummings explores the delicate balance between innovation and oversight. He reveals why traditional regulatory frameworks are struggling to keep pace and how "information hazards" are forcing scientists to rethink transparency itself.

We dive into the ethical minefield of black-boxed AI systems, designing biological solutions, the growing trust gap between lab and consumer, and what it means when AI can "de-skill" biotechnology to the point where expertise is no longer required to create dangerous organisms.

Topics covered: CRISPR and gene editing, AI convergence, biosafety and bioweapons, public trust in GMOs, generational attitudes toward biotech, risk communication, international cooperation, and the future of governance in an accelerating technological landscape.